---
title: "Delcath Systems announces 10-year single-centre experience with percutaneous hepatic perfusion system"
date: "2025-12-11T11:27:01.000Z"
publishedDate: "11 décembre 2025"
summary: "Delcath Systems has announced the publication of a retrospective study by leading interventional radiologists and oncologists from Asklepios Hospital Barmbek in Hamburg, Germany. The study, titled ‘Survival outcome after percutaneous hepatic perfusion with high-dose melphalan for liver-dominant metastatic uveal melanoma: A 10-year single-center experience’, was published in the journal Cancers and reports outcomes from 38 consecutive patients [&#8230;] The post Delcath Systems announces 10-year single-centre experience with percutaneous hepatic perfusion system appeared first on Interventional News ."
importance: ""
sourceUrl: "https://interventionalnews.com/delcath-systems-announces-10-year-single-centre-experience-with-percutaneous-hepatic-perfusion-system/"
tags: ["France", "Actualité", "Interventional News — Latest"]
permalink: "/papers/2025-12-11-delcath-systems-announces-10-year-single-centre-experience-with-percutaneous-hepatic-perfusion-system"
imageUrl: "http://interventionalnews.com/wp-content/uploads/sites/13/2023/03/Delcath-1.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://interventionalnews.com/delcath-systems-announces-10-year-single-centre-experience-with-percutaneous-hepatic-perfusion-system/"
---

![Delcath Systems announces 10-year single-centre experience with percutaneous hepatic perfusion system](http://interventionalnews.com/wp-content/uploads/sites/13/2023/03/Delcath-1.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://interventionalnews.com/delcath-systems-announces-10-year-single-centre-experience-with-percutaneous-hepatic-perfusion-system/*

## L’essentiel

Delcath Systems has announced the publication of a retrospective study by leading interventional radiologists and oncologists from Asklepios Hospital Barmbek in Hamburg, Germany. The study, titled ‘Survival outcome after percutaneous hepatic perfusion with high-dose melphalan for liver-dominant metastatic uveal melanoma: A 10-year single-center experience’, was published in the journal Cancers and reports outcomes from 38 consecutive patients [&#8230;] The post Delcath Systems announces 10-year single-centre experience with percutaneous hepatic perfusion system appeared first on Interventional News .

## Lien source

https://interventionalnews.com/delcath-systems-announces-10-year-single-centre-experience-with-percutaneous-hepatic-perfusion-system/
